Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexiletine N-of-1 Trials in Non-Dystrophic Myotonia
NCT02045667Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2014
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mexiletine in non-dystrophic myotonia (NDM), sponsored by Radboud University Medical Center. Started Jan 2014; status: completed.
02
Drugs
mexiletine
03
Conditions
non-dystrophic myotonia (NDM)
Beyond the preview
Go deeper on NCT02045667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02045667.